Bio-Rad Laboratories Inc. (BIO)
NYSE · Healthcare
Bio-Rad Laboratories Inc. EBITDA 2008–2025
Bio-Rad Laboratories Inc. annual/quarterly ebitda history and growth rate from 2009 to 2020. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Bio-Rad Laboratories Inc. ebitda for the quarter ending March 31, 2020 was 108.0 M, a 20.63% increase year-over-year.
- Bio-Rad Laboratories Inc. ebitda for the twelve months ending March 31, 2020 was 335.3 M, a 33.05% increase year-over-year.
- Bio-Rad Laboratories Inc. annual ebitda for 2025 was 212.6 M, a 49.45% decrease from 2024.
- Bio-Rad Laboratories Inc. annual ebitda for 2024 was 420.6 M, a 13.05% decrease from 2023.
- Bio-Rad Laboratories Inc. annual ebitda for 2023 was 483.7 M, a 21.97% decrease from 2022.
- Bio-Rad Laboratories Inc. annual ebitda for 2022 was 619.9 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Bio-Rad Laboratories Inc. EBITDA — FAQ
Bio-Rad Laboratories Inc. (BIO) ebitda over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BIO's ebitda history?
The chart and table above show Bio-Rad Laboratories Inc.'s ebitda by year and by quarter, including the growth rate.